Ming Li

Office phone:
646-888-2371
Office fax:
646-422-0502
E-mail:
lim@mskcc.org
Research topics:
Bone & Marrow Stem Cell Transplantation; Cancer Therapeutics & Drug Development; Cell Biology; Cell Cycle Regulation; Cell Death; Cell Signaling; Gene Regulation; Genetics & Genomics; Immunology; Tumor Growth & Metastasis
Research topics:
Animal Models of Disease; Apoptosis; Cancer Genetics and Epidemiology; Cancer Therapeutics; Cell Cycle Regulation; Development and Differentiation; Gene Therapy; Immunology; Metastasis; Molecular Pathogenesis; Regulation of Gene Expression; Signal Transduction; Transcriptional Regulation; Tumor Growth and Progression

The immune system has evolved to mount robust responses to pathogens while maintaining tolerance to self or innocuous antigens such as those found in commensal bacteria. Our general interest is to understand how this normal immunological function is ensured in health, and how it is dysregulated in disease, with an emphasis on the function and regulation of T lymphocytes.

T cells are important effectors and regulators of the immune system. A functional adaptive immune system is dependent on diverse and self-tolerant T cells, which are generated in the thymus, and are further maintained in peripheral lymphoid organs. Upon encountering antigens, T cells differentiate into various effector and regulatory subsets that play essential roles in immunity to pathogens, and tolerance to self tissues respectively.

Our recent studies have revealed TGF-beta/TGF-beta receptor and Akt/Foxo pathways as important regulators of thymic T cell development, and peripheral T cell homeostasis, tolerance, and immunity. A major current focus in the lab is to study how these evolutionarily ancient signaling modules are rewired to regulate highly specialized T cell activities, and to define their functions in autoimmune diseases, infectious diseases and cancer.